Fig. 4
MRI imaging of patient 2 displaying disease activity. a FLAIR and b T1 weighted MRI with application of gadolinium at day 300 after start of ATRA revealed multiple gadolinium-enhancing lesions
Fig. 4 | Neurological Research and Practice